Mural Oncology (MURA) News Today $2.60 -0.04 (-1.52%) As of 11:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period BlackRock discloses stake in Mural OncologyMay 3 at 10:55 AM | investing.comGoldman Sachs discloses stake in Mural OncologyMay 3 at 10:55 AM | investing.comFORM 8.1(a) & (b) - Mural Oncology plcApril 30, 2025 | globenewswire.com‘Final mark on his legacy’: Wood County artists dedicate work to muralist who died in JanuaryApril 30, 2025 | msn.comLuka Dončić donates entire cost of restoring vandalized Kobe Bryant mural in downtown Los AngelesApril 29, 2025 | msn.comParkwood Master Fund Ltd - Form 8.3 - Mural Oncology PlcApril 24, 2025 | uk.finance.yahoo.comForm 8.3 - Mural Oncology plcApril 22, 2025 | finance.yahoo.comBoston-area cancer research lab to cease drug trials, lay off 117April 22, 2025 | msn.comMass. biotech company cuts 90% of workforceApril 17, 2025 | msn.comForm 8.3 - The Vanguard Group, Inc.: Mural Oncology plcApril 17, 2025 | markets.businessinsider.comMural Oncology to discontinue nemvaleukin development, reduce staff by 90%April 16, 2025 | markets.businessinsider.comMural shuts down lead programme and slashes 90% of staffApril 16, 2025 | finance.yahoo.comBiotech Company Sees Stock Boost Following Major Strategy ShiftApril 15, 2025 | msn.comMural Oncology to Explore Options, Cut 90% of WorkforceApril 15, 2025 | marketwatch.comMural Oncology cuts 90% of staff, pulls plug on cancer drugApril 15, 2025 | bizjournals.comMural Oncology Shares Surge As Company Explores Strategic Alternatives: What's Going On?April 15, 2025 | benzinga.comMural Oncology Announces Plans to Explore Strategic AlternativesApril 15, 2025 | globenewswire.comMural Oncology: Phase 3 Clinical Trial Setback Undermines Company's Future ProspectsMarch 28, 2025 | seekingalpha.comPetri Dish: Late-stage cancer trial halt; Dyne names CFOMarch 27, 2025 | bizjournals.comMural Oncology price target lowered to $6 from $18 at H.C. WainwrightMarch 27, 2025 | markets.businessinsider.comMural Oncology downgraded to Outperform from Strong Buy at Raymond JamesMarch 26, 2025 | markets.businessinsider.comMural Oncology (NASDAQ:MURA) Receives Hold Rating from Jones TradingJones Trading reaffirmed a "hold" rating on shares of Mural Oncology in a research note on Tuesday.March 26, 2025 | marketbeat.comRaymond James downgrades Mural Oncology after ovarian cancer failureMarch 26, 2025 | markets.businessinsider.comMural Oncology halting progress of nemvaleukin trial in ovarian cancerMarch 26, 2025 | markets.businessinsider.comJones Trading Downgrades Mural Oncology (MURA)March 25, 2025 | msn.comMural Oncology to Discontinue Ovarian Cancer Drug Candidate as Trial Misses TargetsMarch 25, 2025 | marketwatch.comAlkermes spinoff Mural plunges on plans to halt ovarian cancer trialMarch 25, 2025 | msn.comMural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57%March 25, 2025 | finance.yahoo.comMural Oncology's Ovarian Cancer Combo Drug Trial Disappoints, Stock PlungesMarch 25, 2025 | benzinga.comMural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with KEYTRUDA® (pembrolizumab) in Patients with Platinum-Resistant Ovarian CancerMarch 25, 2025 | globenewswire.comMural Oncology (MURA) Expected to Announce Earnings on TuesdayMural Oncology (NASDAQ:MURA) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.comQ1 EPS Estimates for Mural Oncology Reduced by HC WainwrightMural Oncology plc (NASDAQ:MURA - Free Report) - Research analysts at HC Wainwright cut their Q1 2025 earnings estimates for Mural Oncology in a research report issued to clients and investors on Wednesday, March 12th. HC Wainwright analyst A. Maldonado now anticipates that the company will earnMarch 17, 2025 | marketbeat.comMural Oncology enters agreement for share salesMarch 13, 2025 | investing.comHC Wainwright Reiterates "Buy" Rating for Mural Oncology (NASDAQ:MURA)HC Wainwright reiterated a "buy" rating and set a $18.00 target price on shares of Mural Oncology in a research report on Wednesday.March 13, 2025 | marketbeat.comMural Oncology (NASDAQ:MURA) Issues Earnings Results, Misses Expectations By $0.05 EPSMural Oncology (NASDAQ:MURA - Get Free Report) announced its earnings results on Tuesday. The company reported ($2.01) earnings per share for the quarter, missing analysts' consensus estimates of ($1.96) by ($0.05).March 12, 2025 | marketbeat.comAnalysts Offer Insights on NA Companies: Viking Holdings Ltd (VIK) and Mural Oncology Plc (MURA)March 12, 2025 | markets.businessinsider.comMural Oncology reports Q4 EPS ($2.01), consensus ($1.96)March 11, 2025 | markets.businessinsider.comMural Oncology Announces Fourth Quarter and Year End 2024 Financial Results and Highlights Upcoming Clinical MilestonesMarch 11, 2025 | globenewswire.comMural Oncology (NASDAQ:MURA) Stock Price Up 1.4% - Here's WhyMural Oncology (NASDAQ:MURA) Trading Up 1.4% - Here's WhyMarch 8, 2025 | marketbeat.comNew mural at St. Christopher's Hospital for Children in North Philadelphia raises mental health awarenessFebruary 19, 2025 | msn.comMural Oncology to Present at the TD Cowen 45th Annual Health Care ConferenceFebruary 18, 2025 | globenewswire.comMural Oncology plc (NASDAQ:MURA) Short Interest UpdateMural Oncology plc (NASDAQ:MURA - Get Free Report) was the target of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 396,800 shares, a drop of 25.2% from the January 15th total of 530,200 shares. Based on an average daily volume of 206,900 shares, the short-interest ratio is presently 1.9 days. Currently, 2.6% of the shares of the company are short sold.February 15, 2025 | marketbeat.comMural Oncology (NASDAQ:MURA) Trading 8.8% Higher - Here's WhyMural Oncology (NASDAQ:MURA) Trading Up 8.8% - Here's What HappenedFebruary 7, 2025 | marketbeat.comTwin Falls High School senior, cancer survivor brightens up the hallways with a muralJanuary 31, 2025 | msn.comJones Trading Initiates Coverage of Mural Oncology (MURA) with Buy RecommendationJanuary 28, 2025 | msn.comJones Trading sets $16 target on Mural Oncology stockJanuary 27, 2025 | msn.comJonesTrading Initiates a Buy Rating on Mural Oncology Plc (MURA)January 27, 2025 | markets.businessinsider.comMural Oncology initiated with a Buy at JonesResearchJanuary 27, 2025 | markets.businessinsider.comMural Oncology Highlights Pipeline Progress and Anticipated 2025 CatalystsJanuary 9, 2025 | globenewswire.comLouis Nelson, Designer of Korean War Mural, Dies at 88December 14, 2024 | nytimes.com Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address MURA Media Mentions By Week MURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MURA News Sentiment▼0.130.73▲Average Medical News Sentiment MURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MURA Articles This Week▼53▲MURA Articles Average Week Get Mural Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for MURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Esperion Therapeutics News Today Actuate Therapeutics News Today Journey Medical News Today Innate Pharma News Today TuHURA Biosciences News Today AC Immune News Today Canopy Growth News Today Molecular Partners News Today Korro Bio News Today Inhibikase Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MURA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MURA Stock Free MURA Stock Alerts